Pfizer and its German partner, BioNTech, secured a nearly $2 billion order from the U.S. government for 100 million doses of a COVID-19 vaccine that doesn’t yet exist. Under the agreement, the U.S. can acquire up to 500 million additional doses.

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en